Biocept, Inc.
Biocept, Inc. (BIOC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BIOC · as of Jun 8, 2026
Key Statistics
Explore Biocept, Inc. Data
bioc stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 33.3%
Competitors & Peers
bioc competitorsBIOC
ATLN
GBS
LFLY
OTRK
PHGEStock Performance
Full HistoryAbout Biocept, Inc.
Biocept, Inc. is a company specializing in molecular diagnostics for cancer, primarily focused on developing and commercializing advanced diagnostic assays based on proprietary technology. These tests…
what is biocept, inc. · bioc stock overview · biocept, inc. company profile · who is biocept, inc. ceo · bioc NASDAQ · biocept, inc. headquarters · biocept, inc. business segments
About Stock Overview & Key Data
Biocept, Inc. (BIOC) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Feb 5, 2014. As of the latest trading session, BIOC stock price is $0.43, with a market capitalization of $450,786. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Biocept, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2022, Biocept, Inc. reported revenue of $25.9M and net income of -$32.1M. For detailed data — including Biocept, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Biocept, Inc. (BIOC) stock price is $0.43. The stock is traded on NASDAQ under the ticker symbol BIOC. The 52-week range is $0.43 – $0.43.